← Back
▲ BUY
6 / 10

Conviction

$ Value

$20K

Shares

7,415

Price

$3

Filed

Jun 24

Why this score? (6/10)
  • Open market buy (+3)
  • Cluster: 5 insiders buying (+2)
  • Not a 10b5-1 plan (+1)

Insider

Name

Hall Brett Matthew

Title

CHIEF SCIENTIFIC OFFICER

CIK

0001870437

Roles

Officer

Transaction Details

Transaction Date

2025-06-20

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

353,311

Footnotes

This transaction was executed in multiple trades through a broker-dealer at prices ranging from $2.4101 to $2.4299. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.

Filing Info

Accession No.

0001790340-25-000087

Form Type

4

Issuer CIK

0001790340

Hall Brett Matthew's History

Date Ticker Type Value
2026-02-03 IMRX A $0
2026-01-15 IMRX $11K
2025-09-15 IMRX A $21K
2025-06-23 IMRX $15K
2025-06-20 IMRX $20K

Other Insiders at IMRX (90d)

Insider Bought Sold Last
Matushansky Igor
Chief Medical Officer
2026-02-03
Bookman Michael
CHIEF LEGAL OFFICER, SECRETARY
2026-02-03
Zeskind Benjamin J.
PRESIDENT AND CEO
2026-02-03
Hall Brett Matthew
CHIEF SCIENTIFIC OFFICER
2026-02-03
Morales Mallory
SVP Finance, CAO
2026-02-03
Neufeld Leah R
CHIEF PEOPLE OFFICER
2026-03-13
Brakewood Harold Eugene
Chief Business Officer
2026-02-03